Literature DB >> 9650978

Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type.

J A Elliott1, K D Farmer, R R Facklam.   

Abstract

Until recently, group B streptococcus, serotype V (GBS-V), was an infrequent cause of disease. It is now recognized as a significant cause of infections in both children and adults. To determine if this increase was due to the recent introduction and spread of a single clone of GBS-V, we analyzed, by pulsed-field gel electrophoresis (PFGE), the SmaI chromosomal DNA digests of 45 bacteria: 41 isolated from human infections between 1986 and 1996 in the United States, 2 from human infections in Argentina, and 2 from naturally infected mice. Seventeen patterns were found and arbitrarily designated patterns A to Q. Pattern N constituted 24 (53%) of the isolates and was found in all of the years tested and from all surveillance areas, as well as in both isolates from Argentina, and was very similar to the GBS-V isolated from a mouse. Pattern P was found in three isolates, pattern F was found in two, and the remaining patterns were found in one isolate each. We concluded that the majority of isolates of GBS-V are of one PFGE subtype and that this subtype was predominate before the increase in disease caused by GBS-V and that GBS-V disease is caused by several different subtypes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9650978      PMCID: PMC104994     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Typing of group B streptococci: comparison of pulsed-field gel electrophoresis and conventional electrophoresis.

Authors:  M E Gordillo; K V Singh; C J Baker; B E Murray
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

2.  The changing spectrum of group B streptococcal disease.

Authors:  M R Wessels; D L Kasper
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

3.  Emergence of serotype V group B streptococcal infection among infants and adults.

Authors:  L H Harrison; D M Dwyer; J A Johnson
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

4.  Worldwide distribution of two new serotypes of group B streptococci: type IV and provisional type V.

Authors:  J Jelínková; J Motlová
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

5.  Nontypable group B streptococci isolated from human sources.

Authors:  H W Wilkinson
Journal:  J Clin Microbiol       Date:  1977-08       Impact factor: 5.948

6.  Invasive group B streptococcal disease: the emergence of serotype V.

Authors:  H M Blumberg; D S Stephens; M Modansky; M Erwin; J Elliot; R R Facklam; A Schuchat; W Baughman; M M Farley
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

7.  Invasive group B streptococcal disease in children beyond early infancy.

Authors:  S M Hussain; G S Luedtke; C J Baker; P M Schlievert; R J Leggiadro
Journal:  Pediatr Infect Dis J       Date:  1995-04       Impact factor: 2.129

8.  Relapsing invasive group B streptococcal infection in adults.

Authors:  L H Harrison; A Ali; D M Dwyer; J P Libonati; M W Reeves; J A Elliott; L Billmann; T Lashkerwala; J A Johnson
Journal:  Ann Intern Med       Date:  1995-09-15       Impact factor: 25.391

  8 in total
  34 in total

1.  Rapid pulsed-field gel electrophoresis method for group B streptococcus isolates.

Authors:  J A Benson; P Ferrieri
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

2.  Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci.

Authors:  Daniel J Diekema; Janet I Andrews; Holly Huynh; Paul R Rhomberg; Stella R Doktor; Jill Beyer; Virginia D Shortridge; Robert K Flamm; Ronald N Jones; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

3.  Prevalence of group A streptococcal carriers in asymptomatic children and clonal relatedness among isolates in Malatya, Turkey.

Authors:  Riza Durmaz; Bengul Durmaz; Mehmet Bayraktar; Ibrahim Halil Ozerol; Mahmut Tayyar Kalcioglu; Elif Aktas; Zeynep Cizmeci
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

4.  A serotype V clone is predominant among erythromycin-resistant Streptococcus agalactiae isolates in a southwestern region of Germany.

Authors:  Ulrich von Both; Michael Ruess; Urban Mueller; Kirsten Fluegge; Anna Sander; Reinhard Berner
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

5.  Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital.

Authors:  Claire Poyart; Laurence Jardy; Gilles Quesne; Patrick Berche; Patrick Trieu-Cuot
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

6.  Heterogeneity of genotype-phenotype correlation among macrolide-resistant Streptococcus agalactiae isolates.

Authors:  Ulrich von Both; Anna Buerckstuemmer; Kirsten Fluegge; Reinhard Berner
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  Streptococcus pneumoniae isolates resistant to telithromycin.

Authors:  M Rantala; M Haanperä-Heikkinen; M Lindgren; H Seppälä; P Huovinen; J Jalava
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

8.  First isolation of vancomycin-resistant enteroccoci and spread of a single clone in a university hospital in northwestern Turkey.

Authors:  F B Comert; C Kulah; E Aktas; N Ozlu; G Celebi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-01       Impact factor: 3.267

9.  Serotypes and genotypes of erythromycin-resistant group B streptococci in Korea.

Authors:  Young Uh; In Ho Jang; Gyu Yel Hwang; Mi Kyung Lee; Kap Jun Yoon; Hyo Youl Kim
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

10.  Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae.

Authors:  Young Uh; Hyo Youl Kim; In Ho Jang; Gyu Yel Hwang; Kap Jun Yoon
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.